🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Steven Cohen’s CAPR Holdings & Trades

First Buy
Q3 2024
Duration Held
4 Quarters
Largest Add
Q4 2025
+1.72 M Shares
Current Position
1.84 M Shares
$53.1 M Value

Steven Cohen's CAPR Position Overview

Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.84 M shares of Capricor Therapeutics, Inc. (CAPR) worth $53.1 M, representing 0.06% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 4 quarters.

Based on 13F filings, Steven Cohen has maintained this position in CAPR for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 1.72 M shares. Largest reduction occurred in Q4 2024, reducing 250,204 shares.

Analysis based on 13F filings available since 2013 Q2

Steven Cohen's Capricor Therapeutics (CAPR) Holding Value Over Time

Track share changes against reported price movement

Quarterly Capricor Therapeutics (CAPR) Trades by Steven Cohen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +1.72 M Add 1451.45% 1.84 M $28.86
Q3 2025 +118,591 New Buy 118,591 $7.21
Q4 2024 -250,204 Sold Out 0 $0.00
Q3 2024 +250,204 New Buy 250,204 $15.21

Steven Cohen's Capricor Therapeutics Investment FAQs

Steven Cohen first purchased Capricor Therapeutics, Inc. (CAPR) in Q3 2024, acquiring 250,204 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Steven Cohen has held Capricor Therapeutics, Inc. (CAPR) for 4 quarters since Q3 2024.

Steven Cohen's largest addition to Capricor Therapeutics, Inc. (CAPR) was in Q4 2025, adding 1,839,876 shares worth $53.1 M.

According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,839,876 shares of Capricor Therapeutics, Inc. (CAPR), valued at approximately $53.1 M.

As of the Q4 2025 filing, Capricor Therapeutics, Inc. (CAPR) represents approximately 0.06% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.

Steven Cohen's peak holding in Capricor Therapeutics, Inc. (CAPR) was 1,839,876 shares, as reported at the end of Q4 2025.